---
title: "Novo Nordisk AS announced that the clinical trial results of Wegovy show that the drug has benefits for heart health."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/109572654.md"
description: "Novo Nordisk's Wegovy has been approved by the U.S. Food and Drug Administration (FDA), and clinical trial results show that the drug has benefits for heart health."
datetime: "2024-03-08T19:08:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/109572654.md)
  - [en](https://longbridge.com/en/news/109572654.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/109572654.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/109572654.md) | [繁體中文](https://longbridge.com/zh-HK/news/109572654.md)


# Novo Nordisk AS announced that the clinical trial results of Wegovy show that the drug has benefits for heart health.

Novo Nordisk's Wegovy has been approved by the U.S. Food and Drug Administration (FDA), and clinical trial results show that the drug has benefits for heart health.

Novo Nordisk's ADR narrowed its decline to less than 2%.

### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market](https://longbridge.com/en/news/281394441.md)
- [INSTANT VIEW-Lilly gets FDA nod for oral obesity pill, analysts see strong uptake potential](https://longbridge.com/en/news/281409741.md)
- [Here's How Much $100 Invested In abrdn Physical Silver Shares ETF 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/281394387.md)
- [BREAKINGVIEWS-SpaceX IPO will gauge market moxie more than depth](https://longbridge.com/en/news/281406751.md)
- [Palantir vs. Oracle: 1 AI Stock Looks Cheap](https://longbridge.com/en/news/281400403.md)